Lisa Rojkjaer Rigel Pharmaceuticals Inc (RIGL) insider trading activity

RIGL Quotes by TradingView

Lisa Rojkjaer is EVP, Chief Medical Officer of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 19,717 shares of RIGL, which is worth approximately $449,547. The most recent transaction as insider was on Jan 29, 2025, when has been sold 19,717 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.7K
n/a 3M change
n/a 12M change
Total Value Held $449,547

Lisa Rojkjaer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 29 2025
BUY
Grant, award, or other acquisition
-
19,717 Added 50.0%
19,717 Common Stock

Also insider at

VIRX
Viracta Therapeutics, Inc. Healthcare
Chief Medical Officer
LR

Lisa Rojkjaer

EVP, Chief Medical Officer
Cardiff, CA

Track Institutional and Insider Activities on RIGL

Follow RIGEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RIGL shares.

Notify only if

Insider Trading

Get notified when an Rigel Pharmaceuticals Inc insider buys or sells RIGL shares.

Notify only if

News

Receive news related to RIGEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RIGL